help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Evans, S. J.
Right arrow Articles by Moore, F. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evans, S. J.
Right arrow Articles by Moore, F. L.
Endocrinology Vol. 141, No. 7 2294-2300
Copyright © 2000 by The Endocrine Society


ARTICLES

A Subset of Kappa Opioid Ligands Bind to the Membrane Glucocorticoid Receptor in an Amphibian Brain

Simon J. Evans, Brian T. Searcy and Frank L. Moore

Zoology Department, Oregon State University, Corvallis, Oregon 97331

Address all correspondence and requests for reprints to: Frank L. Moore, Zoology Department, Oregon State University, Corvallis, Oregon 97331. E-mail: mooref{at}bcc.orst.edu

Previous studies demonstrated that a membrane receptor for glucocorticoids (mGR) exists in neuronal membranes from the roughskin newt (Taricha granulosa) and that this receptor appears to be a G protein-coupled receptor (GPCR). The present study investigated the question of whether this mGR recognizes nonsteroid ligands that bind to cognate receptors in the GPCR superfamily. To address this question, ligand-binding competition studies evaluated the potencies of various ligands to displace [3H]corticosterone (CORT) binding to neuronal membranes. Initial screening studies tested 21 different competitors and found that [3H]CORT binding was displaced only by dynorphin 1–13 amide (an endogenous {kappa}-selective opioid peptide), U50,488 (a synthetic {kappa}-specific agonist) and naloxone (a nonselective opioid antagonist). Follow-up studies revealed that the {kappa} agonists bremazocine (BRE) and ethylketocyclazocine (EKC) also displaced [3H]CORT binding to neuronal membranes, but that U69,593 (a {kappa} specific agonist) and nor-BNI (a {kappa} specific antagonist) were ineffective. The Ki values measured for the opioid competitors were in the subnanomolar to low micromolar range and had the following rank-order: dynorphin > U50,488 > naloxone > BRE > EKC. Because these ligands displaced, at most, only 70% of [3H]CORT specific binding, it appears that some [3H]CORT binding sites are opioid insensitive. Kinetic analysis of [3H]CORT off-rates in the presence of U50,488 and/or CORT revealed no differences in dissociation rate constants, suggesting that there is a direct, rather than allosteric, interaction with the [3H]CORT binding site. In summary, these results are consistent with the hypothesis that the high-affinity membrane binding site for [3H]CORT is located on a {kappa} opioid-like receptor.




This article has been cited by other articles:


Home page
EndocrinologyHome page
P. Thomas, Y. Pang, J. Dong, P. Groenen, J. Kelder, J. de Vlieg, Y. Zhu, and C. Tubbs
Steroid and G Protein Binding Characteristics of the Seatrout and Human Progestin Membrane Receptor {alpha} Subtypes and Their Evolutionary Origins
Endocrinology, February 1, 2007; 148(2): 705 - 718.
[Abstract] [Full Text] [PDF]


Home page
Integr. Comp. Biol.Home page
J. G. Tasker, S. Di, and R. Malcher-Lopes
Rapid Central Corticosteroid Effects: Evidence for Membrane Glucocorticoid Receptors in the Brain
Integr. Comp. Biol., August 1, 2005; 45(4): 665 - 671.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Maier, D. Runzler, J. Schindelar, G. Grabner, W. Waldhausl, G. Kohler, and A. Luger
G-protein-coupled glucocorticoid receptors on the pituitary cell membrane
J. Cell Sci., August 1, 2005; 118(15): 3353 - 3361.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
C S. Bradford, E. A Walthers, B. T Searcy, and F. L Moore
Cloning, heterologous expression and pharmacological characterization of a kappa opioid receptor from the brain of the rough-skinned newt, Taricha granulosa
J. Mol. Endocrinol., June 1, 2005; 34(3): 809 - 823.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Hatzoglou, M. Kampa, C. Kogia, I. Charalampopoulos, P. A. Theodoropoulos, P. Anezinis, C. Dambaki, E. A. Papakonstanti, E. N. Stathopoulos, C. Stournaras, et al.
Membrane Androgen Receptor Activation Induces Apoptotic Regression of Human Prostate Cancer Cells in Vitro and in Vivo
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 893 - 903.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. S. Watson and B. Gametchu
Proteins of Multiple Classes May Participate in Nongenomic Steroid Actions
Experimental Biology and Medicine, December 1, 2003; 228(11): 1272 - 1281.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Chiyo, T. Yamazaki, K. Aoshika, S. Kominami, and Y. Ohta
Corticosterone Enhances Adrenocorticotropin-Induced Calcium Signals in Bovine Adrenocortical Cells
Endocrinology, August 1, 2003; 144(8): 3376 - 3381.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. M. LOSEL, E. FALKENSTEIN, M. FEURING, A. SCHULTZ, H.-C. TILLMANN, K. ROSSOL-HASEROTH, and M. WEHLING
Nongenomic Steroid Action: Controversies, Questions, and Answers
Physiol Rev, July 1, 2003; 83(3): 965 - 1016.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society